Liposomal Amikacin for Inhalation

amikacin liposome inhalation suspension · Insmed Incorporated

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Liposomal Amikacin for Inhalation, covering 2019-07-26 to 2020-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease [Phase 2]